The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis

• Published in: International journal of molecular sciences Vol. 19; no. 12; p. 3796
• Main Authors: Schwenkenbecher, Philipp, Konen, Franz Felix, Wurster, Ulrich, Jendretzky, Konstantin Fritz, Gingele, Stefan, Sühs, Kurt-Wolfram, Pul, Refik, Witte, Torsten, Stangel, Martin, Skripuletz, Thomas
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 29-11-2018; MDPI
• Subjects: Cerebrospinal fluid; Chains; clinically isolated syndrome; Converters; Criteria; Demyelination; Diagnosis; Gels; Immunoglobulin G; Immunoglobulins; kappa free light chains; Light chains; Magnetic resonance imaging; McDonald criteria; Multiple sclerosis; Nephelometry; oligoclonal bands; Patients; Polyacrylamide; polyacrylamide gel; McDonald criteria; kappa free light chains; polyacrylamide gel; clinically isolated syndrome; multiple sclerosis; oligoclonal bands
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms19123796

The latest revision of the McDonald criteria of 2017 considers the evidence of an intrathecal immunoglobulin (IgG) synthesis as a diagnostic criterion for dissemination in time in multiple sclerosis. While the detection of oligoclonal bands is considered as the gold standard, determination of kappa free light chains might be a promising tool as a less technically demanding and cost saving method. However, data on the direct comparison between kappa free light chains and oligoclonal bands are limited and no study to date has used the highly sensitive method of polyacrylamide gels with consecutive silver staining for the demonstration of oligoclonal bands. Furthermore, the impact of the revised McDonald criteria of 2017 on the role of kappa free light chains as a biomarker has not been investigated. Nephelometry was used to determine kappa free light chains in cerebrospinal fluid (CSF) and serum from 149 patients with their first demyelinating event between 2010 and 2015. Clinical data, kappa free light chains, and oligoclonal band status were compared at the time of initial diagnosis and after follow-up to identify converters from clinically isolated syndrome to multiple sclerosis. An elevated kappa free light chain index (>5.9) was found in 79/83 patients (95%) with multiple sclerosis diagnosed at baseline, slightly less frequent than oligoclonal bands (98.8%). 18/25 (72%) patients who converted from clinically isolated syndrome to multiple sclerosis showed an elevated kappa free light chain index compared to 20/25 (80%) patients with positive oligoclonal bands. In patients with stable clinically isolated syndrome 7/41 (17%) displayed an elevated kappa free light chain index against 11/41 (27%) oligoclonal band positive patients. Only two patients with stable clinically isolated syndrome showed an elevated kappa free light chain index but were oligoclonal bands negative. In conclusion, determination of the kappa free light chain index is a promising diagnostic approach to assess intrathecal immunoglobulin synthesis in multiple sclerosis. Nevertheless, oligoclonal bands are highly prevalent in multiple sclerosis and can detect an intrathecal synthesis of IgG even when the kappa free light chain index is below the threshold. We consider sequential use of both methods as reasonable.